title: Triple diagnosis: dual diagnosis and HIV disease, part 2.
abstract: This review highlights the psychiatric, psychosocial, and substance use treatment issues relevant to the care of patients with triple diagnosis. A discussion of the various psychosocial and psychopharmacologic strategies stresses the importance of integrating medical, psychiatric, and substance use interventions. Components of integrated treatment include a collaborative relationship with various medical services involved in the patient's care, psychotherapeutic interventions tailored to the patient's readiness for change and incorporating motivational strategies, special attention to psychosocial needs, strong emphasis on psychoeducation, and psychopharmacologic management. More research is warranted to evaluate the safety and efficacy of psychopharmacologic and psychotherapeutic modalities in patients with triple diagnosis.
authors.affiliation: University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
authors.forename: Antoine B
authors.initials: AB
authors.lastname: Douaihy
authors.forename: Roger J
authors.initials: RJ
authors.lastname: Jou
authors.forename: Tad
authors.initials: T
authors.lastname: Gorske
authors.forename: Ihsan M
authors.initials: IM
authors.lastname: Salloum
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use; D001294:Attitude to Health; D003266:Continuity of Patient Care / Q000458:organization & administration*; D003299:Cooperative Behavior; D017831:Diagnosis, Dual (Psychiatry) / Q000379:methods; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000150:complications / Q000175:diagnosis / Q000523:psychology / Q000628:therapy*; D006801:Humans; D001523:Mental Disorders / Q000150:complications / Q000175:diagnosis / Q000523:psychology / Q000628:therapy*; D008691:Methadone / Q000627:therapeutic use; D008960:Models, Psychological; D009042:Motivation; D020380:Needs Assessment; D010348:Patient Care Team / Q000458:organization & administration; D010353:Patient Education as Topic; D011600:Psychopharmacology; D011613:Psychotherapy / Q000458:organization & administration; D011619:Psychotropic Drugs / Q000627:therapeutic use; D012449:Safety; D019966:Substance-Related Disorders / Q000150:complications / Q000175:diagnosis / Q000523:psychology / Q000628:therapy*
chemical_list: D019380:Anti-HIV Agents; D011619:Psychotropic Drugs; D008691:Methadone